Melanotic Neuroectodermal Tumour of Infancy.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Country of Publication: United States NLM ID: 101304010 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0568 (Electronic) Linking ISSN: 1936055X NLM ISO Abbreviation: Head Neck Pathol Subsets: MEDLINE
    • Publication Information:
      Publication: June 2011- : New York : Springer Science+ Business Media
      Original Publication: Secaucus, NJ : Humana Press
    • Subject Terms:
    • Abstract:
      Melanotic neuroectodermal tumour of infancy (MNTI) is a locally aggressive neoplasm of neural crest origin. It is primarily a paediatric tumour, and 95% of the cases occur in children below 1 year. The tumour mainly affects the head and neck region. It shows a predilection for the craniofacial sites and the most common site affected is anterior maxilla. Microscopically, it is characterized by a biphasic population of neuroblastic cells and pigmented epithelial cells. Although generally considered as a benign tumour, it can invade the adjacent muscle and bone, causing destruction of the involved site. The rapidity in growth and the aggressive clinical behaviour of the tumour can be deceptive and hence lack of familiarity with the clinical characteristics of the tumour may often lead to an erroneous diagnosis of malignancy. The treatment of choice for MNTI is excision, and it is usually curative. Extensive surgery in a child may interfere with the normal growth and development of the facial structures and reconstruction can be very challenging in infants. Hence, early diagnosis is critical for the effective management. Clinical findings, histopathological features, and differential diagnosis of a classic case of melanotic neuroectodermal tumour of infancy are discussed.
      (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
    • References:
      Pediatrics. 2015 Jul;136(1):e267-9. (PMID: 26122804)
      Cancer. 1951 Jan;4(1):78-85. (PMID: 14801773)
      Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Aug;102(2):204-16. (PMID: 16876064)
      BMJ Case Rep. 2022 Jan 4;15(1):. (PMID: 34983807)
      Proc R Soc Med. 1926;19(Odontol Sect):11-21. (PMID: 19985112)
      AJNR Am J Neuroradiol. 1995 May;16(5):1176-8. (PMID: 7639150)
      Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Feb;121(2):173-9. (PMID: 26686956)
      Ultrasound Obstet Gynecol. 2015 Aug;46(2):249-50. (PMID: 25594399)
      Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4629-4635. (PMID: 27107579)
      J Oral Maxillofac Surg. 2016 Dec;74(12):2431-2440. (PMID: 27393580)
      J Indian Assoc Pediatr Surg. 2021 Jul-Aug;26(4):265-267. (PMID: 34385774)
      J Oral Maxillofac Surg. 1991 Sep;49(9):1018-22. (PMID: 1886013)
      J Pediatr Hematol Oncol. 2007 Dec;29(12):854-7. (PMID: 18090938)
      BMC Cancer. 2016 Aug 12;16:629. (PMID: 27519597)
      Head Neck. 2018 Dec;40(12):2749-2756. (PMID: 30390348)
      Turk J Pediatr. 2009 Sep-Oct;51(5):507-9. (PMID: 20112611)
      Pediatr Blood Cancer. 2004 Jan;42(1):64-73. (PMID: 14752797)
      J Pediatr Surg. 2008 Jun;43(6):E25-9. (PMID: 18558161)
      Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Jun;93(6):688-98. (PMID: 12142876)
    • Contributed Indexing:
      Keywords: Early diagnosis; Infant; Maxilla; Melanotic; Neural crest; Neuroectodermal tumour
    • Publication Date:
      Date Created: 20230228 Date Completed: 20230628 Latest Revision: 20240229
    • Publication Date:
      20240229
    • Accession Number:
      PMC10293543
    • Accession Number:
      10.1007/s12105-023-01537-x
    • Accession Number:
      36853558